Asia-Pacific Ultra Low Freezers Market, By Type (Product and Freezer Part and Accessories), Technology (Semi-Automated Freezers and Automated Freezers), Degree Of Cooling (-41°C To -86° C Freezers, -87°C To -150° C Freezers, and -10°C To -40° C Freezers), Insulated Material (Polyurethane Foam, Vacuum Panel And Others), Application (Organs, Blood & Blood Products, Biological Samples, Drug Compounds, and Others), End-Users (Hospitals, Bio-Banks, Clinics, Corporate Laboratories, Pharmaceuticals, Academic and Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Third Party Distribution) - Industry Trends and Forecast to 2030.
Asia-Pacific Ultra Low Freezers Market Analysis and Size
The rising public awareness regarding cancer and genetic disorders has enhanced the demand for the market. The major market players focus on various product launches and approvals during this crucial period. In addition, the increase in improved and advancement in technology is also contributing to the rising demand for the market.
The Asia-Pacific ultra low freezers market is expected to grow in the forecast period of 2023 to 2030 due to the rise in cancer and other chronic diseases. The high funding for research activities by the government and other bodies is also expected to drive market growth. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market. However, the high cost of the products is expected to restrain the market growth. The growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine is expected to boost the market growth. However, the rising competition among market players and the lack of skilled and certified professionals are expected to challenge market growth.
Data Bridge Market Research analyzes that the Asia-Pacific ultra low freezers market is expected to reach the value of USD 224.32 million by 2030, at a CAGR of 7.0% during the forecast period. The type segment accounts for the largest segment in the market due to the rising number of cancer and genetic disorders among patients. This market report also covers pricing analysis and technological advancements in depth.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Product and Freezer Part and Accessories), Technology (Semi-Automated Freezers and Automated Freezers), Degree Of Cooling (-41°C To -86° C Freezers, -87°C To -150° C Freezers, and -10°C To -40° C Freezers), Insulated Material (Polyurethane Foam, Vacuum Panel And Others), Application (Organs, Blood & Blood Products, Biological Samples, Drug Compounds, and Others), End-Users (Hospitals, Bio-Banks, Clinics, Corporate Laboratories, Pharmaceuticals, Academic and Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Third Party Distribution)
|
|
Countries Covered
|
China, Japan, India, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore and Rest of Asia Pacific.
|
|
Market Players Covered
|
PHC Corporation, Eppendorf SE, FUKUSHIMA GALILEI CO.LTD., Thermo Fisher Scientific Inc., BINDER GmbH, REMI GROUP, B Medical Systems, AticoExport, VWR International, LLC., BIOWAY CORPORATION, NuAire, Inc., BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Esco Micro Pte. Ltd., Helmer Scientific Inc., Telstar, BioLife Solutions Inc., among others
|
Market Definition
Ultra low freezers, often abbreviated as ULT freezers, represent a specialized segment within the refrigeration industry. These are highly sophisticated and technologically advanced devices designed for the preservation of biological and pharmaceutical samples at extremely low temperatures. They are a crucial tool in scientific and medical research, besides in various industries such as biotechnology and pharmaceuticals. Marketed primarily to research institutions, laboratories, hospitals, and pharmaceutical companies, ultra-low freezers are indispensable for the long-term storage of valuable biological materials such as DNA, RNA, proteins, vaccines, and other temperature-sensitive samples. With the growing importance of life sciences research and the need for reliable cold storage solutions, the ultra-low freezer market has witnessed substantial growth, with manufacturers continually innovating to improve energy efficiency, temperature stability, and storage capacity.
Asia-Pacific Ultra Low Freezers Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing Demand for Biopharmaceuticals and Vaccines
The rising demand for biopharmaceuticals and vaccines can be attributed to several interconnected factors. Firstly, advances in biotechnology and genomics have transformed the pharmaceutical industry. Techniques such as CRISPR-Cas9 have revolutionized gene editing, enabling the development of highly targeted treatments and vaccines. Secondly, increasing Asia-Pacific health concerns, exemplified by the COVID-19 pandemic, have underscored the necessity of vaccines in controlling infectious diseases. Additionally, the emergence of antibiotic-resistant bacteria highlights the importance of continuous research and development in biopharmaceuticals and vaccines.
- RISING Research and Development Activities in Life Sciences
The rising research and development (R&D) activities in the life sciences represent a thriving and multifaceted domain at the intersection of biology, medicine, technology, and sustainability. This surge in R&D can be attributed to several interconnected factors.
Firstly, rapid technological advancements, such as genomics, CRISPR-Cas9 gene editing, and high-throughput screening, have revolutionized how scientists study and manipulate biological systems, fostering a fertile ground for innovation and discovery. These tools enable researchers to decode genomes, identify disease markers, and develop novel therapies with unprecedented precision.
Secondly, the persistent challenge of emerging diseases such as Zika and the seismic impact of the COVID-19 pandemic underscore the vital importance of life sciences R&D. Scientists are working tirelessly to develop vaccines, treatments, and diagnostics for these threats, highlighting the need for ongoing research to safeguard Asia-Pacific health.
Restraints/ Challenges
- High Installation and Operational Cost of Ultra Low Freezers
Ultra low freezers are essential equipment in various scientific and medical fields, particularly in research, healthcare, and pharmaceutical industries. These freezers are designed to maintain extremely low temperatures, typically around -80°C or even lower, to preserve valuable biological samples, vaccines, drugs, and other temperature-sensitive materials.
While they offer precise temperature control and sample protection, they come with high installation and operational costs for several reasons such as:
Specialized Design: Ultra low freezers are purpose-built to reach and maintain ultra low temperatures. Achieving and sustaining temperatures as low as -80°C requires specialized compressors, insulation, and refrigerants. This specialized design drives up manufacturing costs.
High-quality Insulation: To maintain such low temperatures, these freezers require high-quality insulation materials such as foamed-in-place polyurethane. This insulation is thicker and more efficient than what is found in standard freezers.
- Temperature Validation and Calibration of Ultra Low Freezers
Temperature validation and calibration for ultra low freezers is a critical process in various industries, such as healthcare, research, and pharmaceuticals, where these freezers are used to store sensitive and valuable materials, including vaccines, biological samples, and chemicals, at extremely low temperatures (typically between -40°C to -80°C). Accurate and consistent temperature control is essential to ensure the integrity and viability of these stored materials.
Additionally, calibration and validation processes can be time-consuming and costly for users, as they may necessitate taking freezers offline temporarily, potentially disrupting operations and requiring additional resources for backup storage and staff training. These challenges can affect market dynamics by influencing the cost of ultra low freezers and adding complexity to their adoption, particularly for smaller organizations or those with limited budgets.
Thus temperature validation and calibration of ultra low freezers is expected to act as challenge for Asia-Pacific ultra low freezers market growth.
Opportunity
- Increasing Demand for Biopreservation and Biobanking
Increasing demand for biopreservation and biobanking can be attributed to several factors, reflecting the growing importance of these practices in various fields such as healthcare, pharmaceuticals, research, and personalized medicine.
Ultra low freezers are vital components in the biobanking infrastructure, providing the necessary storage conditions for preserving a wide range of biological samples. As biobanking facilities proliferate Asia-Pacificly due to advancements in medical research, precision medicine, and pharmaceutical development, the demand for ultra low freezers is surging. Manufacturers in this market have the chance to innovate and offer advanced freezer models with features like energy efficiency and remote monitoring to meet the evolving needs of biobanks.
Recent Developments
- In February 2023, PHC Corporation of North America launched the PHCbibrand VIP ECO SMART series of ultra-low temperature freezers for use in facilities including medical facilities, universities, and pharmaceutical companies. The company's new PHCbibrand VIP ECO SMART series consists of four ultra-low temperature freezers without HFCs, which enable efficient and safe long-term sample storage for researchers involved in drug development and life science research
- In April 2023, Eppendorf launched the Centrifuge 5427 R, the first hydrocarbon-cooled Eppendorf microcentrifuge that contributed to a more sustainable laboratory environment. With this offer, customers can now perform a variety of molecular and cell biology applications using a refrigeration unit that contains a natural refrigerant with near-zero Asia-Pacific warming potential. This launch not only protects the individuals but also the planet.
Asia-Pacific Ultra Low Freezers Market Scope
Asia-Pacific ultra low freezers market is segmented into seven notable segments based on type, technology, degree of cooling, insulated material, application, end-user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Product
- Freezer Parts and Accessories
Based on type, the market is segmented into product, and freezer parts and accessories.
Technology
- Automated Freezers
- Semi- Automated Freezers
Based on technology, the market is segmented into automated freezers and semi-automated freezers.
Degree of Cooling
- -41°C to -86 °C Freezers
- -87°C to -150 °C Freezers
- -10°C to -40 °C Freezers
Based on degree of cooling, the market is segmented into -41°C to -86 °C freezers, -87°C to -150 °C freezers, and -10°C to -40 °C freezers.
Insulated Material
- Polyurethane Foam
- Vacuum Panels
- Others
Based on insulated material the market is segmented into polyurethane foam, vacuum panels, and others.
Application
- Blood & Blood Products
- Biological Samples
- Drug Compounds
- Organs
- Others
Based on application the market is segmented into blood & blood products, biological samples, drug compounds, organs, and others.
End User
- Hospitals
- Corporate Laboratories
- Pharmaceuticals
- Bio-Banks
- Clinics
- Academic and Research Institutes
- Others
Based on end user the market is segmented into hospitals, corporate laboratories, pharmaceuticals, bio-banks, clinics, academic and research institutes, and others.
Distribution Channel
- Direct Tender
- Retail Sales
- Third Party Distributors
Based on distribution channel the market is segmented into direct tenders, retail sales, and third party distributors.
Asia-Pacific Ultra Low Freezers Market Regional Analysis/Insights
Asia-Pacific ultra low freezers market is analyzed and market size insights and trends are provided by country, type, technology, degree of cooling, insulated material, application, end users and distribution channel as referenced above.
The countries covered in this market report China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.
China is expected to dominate the market with the largest market share. This share is attributable to the presence of key market players. Rising demand for biopharmaceuticals and vaccines and technological advancements are anticipated to fuel the market growth during the forecast period in this region.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Ultra Low Freezers market Share Analysis
Asia-Pacific ultra low freezers market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major companies dealing in the market are PHC Corporation, FUKUSHIMA GALILEI CO.LTD., VWR International, LLC., REMI GROUP, Eppendorf SE, Thermo Fisher Scientific Inc., BINDER GmbH, B Medical Systems, AticoExport, BIOWAY CORPORATION, NuAire, Inc., BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Esco Micro Pte. Ltd., Helmer Scientific Inc., Telstar, BioLife Solutions Inc., and among others.
SKU-